# CARDAMYST
> **NDA218571** · New Drug Application · Sponsor: MILESTONE PHARMS USA · Approved 2025-12-12
## Drug
- **FDA Application Number:** NDA218571
- **Application type:** New Drug Application
- **Brand name:** CARDAMYST
- **Generic name:** ETRIPAMIL
- **Active ingredients:** ETRIPAMIL
- **Dosage form:** SPRAY
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** MILESTONE PHARMS USA
- **Manufacturer:** Milestone Pharmaceuticals USA, Inc.
- **First approval:** 2025-12-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218571)
---
*MORVS · CC0 1.0*